Wall Street closes at a record for the first time since end of January
Smith & Nephew plc (LSE:SN, NYSE:SNN) announced Wednesday that Thérèse Esperdy, Senior Independent Director designate, will join the board of Rentokil Initial plc (LSE:RTO) as a Non-Executive Director and Chair-designate effective July 1, 2026. She is set to assume the role of Chair of the Board at Rentokil Initial beginning September 1, 2026.
The announcement was made in accordance with UK Listing Rule 6.4.9R(2), according to a statement released by Smith & Nephew based on a filing with the U.S. Securities and Exchange Commission.
Smith & Nephew is a global medical technology company headquartered in Watford, England, and is a constituent of the FTSE 100 index. Rentokil Initial is listed on the London Stock Exchange.
No additional changes to Smith & Nephew’s board or management structure were disclosed in the filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
